Annual Cash & Cash Equivalents
$49.26 M
+$3.34 M+7.27%
31 December 2023
Summary:
Elevation Oncology annual cash & cash equivalents is currently $49.26 million, with the most recent change of +$3.34 million (+7.27%) on 31 December 2023. During the last 3 years, it has fallen by -$30.14 million (-37.97%). ELEV annual cash & cash equivalents is now -66.33% below its all-time high of $146.28 million, reached on 31 December 2021.ELEV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$48.20 M
-$11.24 M-18.92%
30 September 2024
Summary:
Elevation Oncology quarterly cash and cash equivalents is currently $48.20 million, with the most recent change of -$11.24 million (-18.92%) on 30 September 2024. Over the past year, it has dropped by -$6.68 million (-12.17%). ELEV quarterly cash and cash equivalents is now -69.50% below its all-time high of $158.02 million, reached on 30 June 2021.ELEV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELEV Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | -12.2% |
| 3 y3 years | -38.0% | -68.9% |
| 5 y5 years | - | - |
ELEV Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.3% | +7.3% | -68.9% | +5.0% |
| 5 y | 5 years | -66.3% | +2730.8% | -69.5% | +5.0% |
| alltime | all time | -66.3% | +2730.8% | -69.5% | +5.0% |
Elevation Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.20 M(-18.9%) |
| June 2024 | - | $59.45 M(-34.4%) |
| Mar 2024 | - | $90.63 M(+84.0%) |
| Dec 2023 | $49.26 M(+7.3%) | $49.26 M(-10.2%) |
| Sept 2023 | - | $54.88 M(-48.4%) |
| June 2023 | - | $106.33 M(+90.2%) |
| Mar 2023 | - | $55.90 M(+21.7%) |
| Dec 2022 | $45.92 M | $45.92 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $52.59 M(-2.4%) |
| June 2022 | - | $53.88 M(+1.6%) |
| Mar 2022 | - | $53.01 M(-63.8%) |
| Dec 2021 | $146.28 M(+84.2%) | $146.28 M(-5.7%) |
| Sept 2021 | - | $155.20 M(-1.8%) |
| June 2021 | - | $158.02 M(+126.0%) |
| Mar 2021 | - | $69.91 M(-11.9%) |
| Dec 2020 | $79.40 M(+4463.2%) | $79.40 M |
| Dec 2019 | $1.74 M | - |
FAQ
- What is Elevation Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Elevation Oncology?
- What is Elevation Oncology annual cash & cash equivalents year-on-year change?
- What is Elevation Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Elevation Oncology?
- What is Elevation Oncology quarterly cash and cash equivalents year-on-year change?
What is Elevation Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of ELEV is $49.26 M
What is the all time high annual cash & cash equivalents for Elevation Oncology?
Elevation Oncology all-time high annual cash & cash equivalents is $146.28 M
What is Elevation Oncology annual cash & cash equivalents year-on-year change?
Over the past year, ELEV annual cash & cash equivalents has changed by +$3.34 M (+7.27%)
What is Elevation Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELEV is $48.20 M
What is the all time high quarterly cash and cash equivalents for Elevation Oncology?
Elevation Oncology all-time high quarterly cash and cash equivalents is $158.02 M
What is Elevation Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, ELEV quarterly cash and cash equivalents has changed by -$6.68 M (-12.17%)